Table 4.
Multivariable regression of severe neonatal morbidity by timing of antenatal corticosteroid administration
Severe neonatal morbidity* adjusted odds ratio (95% confidence interval) | p-value | |
---|---|---|
Timing of antenatal corticosteroid administration | ||
< 2 days before delivery | 0.80 (0.59–1.07) | 0.135 |
2 to <7 days before delivery | 1.0 (referent) | - |
7 to <14 days before delivery | 1.15 (0.83–1.58) | 0.404 |
≥ 14 days before delivery | 1.57 (1.12–2.19) | 0.009 |
Gestational age at delivery, per completed week | 0.55 (0.53–0.58) | <0.001 |
Male gender | 1.31 (1.04–1.65) | 0.022 |
Nulliparous mother | 1.18 (0.93–1.49) | 0.185 |
Delivery by cesarean section | 1.23 (0.97–1.56) | 0.092 |
Other factors considered in initial models but removed due to p>0.20 include preterm prelabor rupture of membranes, receipt of magnesium sulfate prior to delivery (for any indication), maternal smoking during pregnancy, black race, and suspected clinical chorioamnionitis.
Composite included death, severe intraventricular hemorrhage grade III or IV, periventricular leukomalacia, bronchopulmonary dysplasia, or necrotizing enterocolitis